Emibetuzumab Completed Phase 2 Trials for Malignant Neoplasm of Stomach Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01874938A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer